Correlation Between China Pharma and Silver Spike
Can any of the company-specific risk be diversified away by investing in both China Pharma and Silver Spike at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Pharma and Silver Spike into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Pharma Holdings and Silver Spike Investment, you can compare the effects of market volatilities on China Pharma and Silver Spike and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Pharma with a short position of Silver Spike. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Pharma and Silver Spike.
Diversification Opportunities for China Pharma and Silver Spike
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between China and Silver is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding China Pharma Holdings and Silver Spike Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silver Spike Investment and China Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Pharma Holdings are associated (or correlated) with Silver Spike. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silver Spike Investment has no effect on the direction of China Pharma i.e., China Pharma and Silver Spike go up and down completely randomly.
Pair Corralation between China Pharma and Silver Spike
If you would invest 1,296 in Silver Spike Investment on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Silver Spike Investment or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 4.55% |
Values | Daily Returns |
China Pharma Holdings vs. Silver Spike Investment
Performance |
Timeline |
China Pharma Holdings |
Silver Spike Investment |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
China Pharma and Silver Spike Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with China Pharma and Silver Spike
The main advantage of trading using opposite China Pharma and Silver Spike positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Pharma position performs unexpectedly, Silver Spike can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silver Spike will offset losses from the drop in Silver Spike's long position.China Pharma vs. Universe Pharmaceuticals | China Pharma vs. Sonoma Pharmaceuticals | China Pharma vs. Akanda Corp | China Pharma vs. Halo Collective |
Silver Spike vs. Entourage Health Corp | Silver Spike vs. Avicanna | Silver Spike vs. Benchmark Botanics | Silver Spike vs. Speakeasy Cannabis Club |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |